Schizophrenia

Submitted by maprc on Tue, 12/06/2011 - 17:06

MAPrc’s researchers are currently working on a number of projects developing new treatments and diagnostic methods for people experiencing schizophrenia

Transcranial direct current stimulation (tDCS)

tDCS for schizophrenia and schizoaffective disorder uses a very mild electrical current to alter the activity in the areas of the brain thought to be related to these illnesses, as an alternative treatment for symptoms such as low motivation, difficulties with concentration and memory, hearing voices and confused thoughts.We are also conducting investigations with tDCS to learn more about the brain basis of schizophrenia, and to develop new treatments.
For further information click here or contact Susan McQueen on 9076 6595 or email s.mcqueen@alfred.org.au

SearchLyte

A randomized study predominately looking at negative symptoms & sub-optimally controlled symptoms in participants with schizophrenia, treated with antipsychotics followed by a double-blind extension period over a period of 4 yrs.
For further information click here or contact Erica Hannagan on 9076 6585 or email e.hannagan@alfred.org.au

Investigating the effects of adjunct glycine therapy on cognitive function in schizophrenia

A six week clinical trial investigating the use of glycine in schizophrenia and its effects on mismatched negativity and EEG cognition.
For more information click here or contact Amity Green on 9076 5180 or email a.green@alfred.org.au

Investigation of Ondansetron in Chronic Residual Schizophrenia

A randomised investigation of ondansetron (an anti nausea medication) in schizophrenia participants.
For further information click here or contact Penny Weeks on 9076 6590 or email p.weeks@alfred.org.au

Selective Estrogen Receptor Modulator (SERM)

Clinical trial of estrogen tablet trial for menopausal women, with schizophrenia or schizoaffective disorder. For further details click here or contact Emmy Gavrilidis on 9076 6913 or email e.gavrilidis@alfred.org.au

NRAMP - National Register for Antipsychotics in Pregnancy

Observational study of women who are taking or have taken antipsychotic medications during their pregnancy. For further information click here or contact Heather Gilbert on 9076 6591 or email h.gilbert@alfred.org.au

EVestG (ElectrovestibuloGraphy)

We are currently trialling a new technique, EVestG (ElectrovestibuloGraphy) which is being investigated as a possible objective method for diagnosing participants with Schizophrenia.
For further information click here or contact Juliana Mitchell-Wong on 9076 6564 or email juliana.mitchell-wong@monash.edu

Memory and Schizophrenia

An investigation of memory problems associated with schizophrenia. For further information, please click here or Erica Neill on 9076 6850 or email e.neill@alfred.org.au

Speech and language

A study examining speech and language difficulties in schizophrenia and how these may influence quality of life. For further information please click here or contact Eric Tan on 9076 3245 or email Eric.Tan@med.monash.edu.au

Hearing and language

A study aimed at understanding whether schizophrenia patients have difficulty hearing simple tones and whether this may relate to language difficulties. For further information please click here or contact Chris Groot on 9076 6850 or email christopher.groot@gmail.com

Relatives of shizophrenia ptients and hearing

A study aimed at understanding whether relatives of schizophrenia patients have difficulty hearing simple tones. For further information please click here or contact Rachel Tucker on 9076 6850 or email rvtucker@students.latrobe.edu.au

Cognitive remediation and vocational training

A study to examine whether cognitive remediation conducted at the same time as vocational training may assist with patients with schizophrenia returning to work. For further information click here or contact Natalia Contreas on 9076 6850 or email nata_cg@hotmail.com

Trauma and auditory hallucinations

An investigation of how trauma may influence the experience of auditory hallucinations. For further information please click here or contact Sarah Brennan on 9076 6850 or email S.Brennan@alfred.org.au

Genes and brain function

An large collaborative investigation examining how genes and brain function influence the production of language symptoms, including auditory hallucinations and confused speech. For futher information click here or contact Erica Neill on 9076 6850 or email e.neill@alfred.org.au